Technology >> Analyst Interviews >> April 21, 2003
CHERI WALKER is a Vice President and Senior Analyst for Deutsche
Bank Securities, Inc., covering life science tools companies and
has focused exclusively on this sector for the past two years.
She joined Deutsche Bank in January 2000 as a Senior Associate
covering life science tools, contract research organization and
distribution stocks and has previous experience in corporate
finance at a regional investment bank and business development at
a private biotechnology company. In addition, she holds a PhD in
human and molecular genetics from Baylor College of Medicine and
a BA in Biology from Swarthmore College. Profile
Dr. Walker: I cover the life science tools companies, which
include reagent names such as Invitrogen (IVGN), QIAGEN (QGENF),
Techne
